This site uses cookies, tags, and tracking settings to store information that help give you the very best browsing experience. Dismiss this warning

Combined gene therapy with vascular endothelial growth factor plus apelin in a chronic cerebral hypoperfusion model in rats

Masafumi Hiramatsu Department of Neurological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences;

Search for other papers by Masafumi Hiramatsu in
Current site
Google Scholar
PubMed
Close
 MD
,
Tomohito Hishikawa Department of Neurological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences;

Search for other papers by Tomohito Hishikawa in
Current site
Google Scholar
PubMed
Close
 MD
,
Koji Tokunaga Department of Neurosurgery, Okayama City Hospital, Okayama; and

Search for other papers by Koji Tokunaga in
Current site
Google Scholar
PubMed
Close
 MD
,
Hiroyasu Kidoya Department of Signal Transduction, Research Institute for Microbial Diseases, Osaka University, Suita, Japan

Search for other papers by Hiroyasu Kidoya in
Current site
Google Scholar
PubMed
Close
 PhD
,
Shingo Nishihiro Department of Neurological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences;

Search for other papers by Shingo Nishihiro in
Current site
Google Scholar
PubMed
Close
 MD
,
Jun Haruma Department of Neurological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences;

Search for other papers by Jun Haruma in
Current site
Google Scholar
PubMed
Close
 MD
,
Tomohisa Shimizu Department of Neurological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences;

Search for other papers by Tomohisa Shimizu in
Current site
Google Scholar
PubMed
Close
 MD
,
Yuji Takasugi Department of Neurological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences;

Search for other papers by Yuji Takasugi in
Current site
Google Scholar
PubMed
Close
 MD
,
Yukei Shinji Department of Neurological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences;

Search for other papers by Yukei Shinji in
Current site
Google Scholar
PubMed
Close
 MD
,
Kenji Sugiu Department of Neurological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences;

Search for other papers by Kenji Sugiu in
Current site
Google Scholar
PubMed
Close
 MD
,
Nobuyuki Takakura Department of Signal Transduction, Research Institute for Microbial Diseases, Osaka University, Suita, Japan

Search for other papers by Nobuyuki Takakura in
Current site
Google Scholar
PubMed
Close
 MD
, and
Isao Date Department of Neurological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences;

Search for other papers by Isao Date in
Current site
Google Scholar
PubMed
Close
 MD
Restricted access

Purchase Now

USD  $45.00

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $536.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $636.00
USD  $45.00
USD  $536.00
USD  $636.00
Print or Print + Online Sign in

OBJECTIVE

The aim of this study was to evaluate whether combined gene therapy with vascular endothelial growth factor (VEGF) plus apelin during indirect vasoreconstructive surgery enhances brain angiogenesis in a chronic cerebral hypoperfusion model in rats.

METHODS

A chronic cerebral hypoperfusion model induced by the permanent ligation of bilateral common carotid arteries (CCAs; a procedure herein referred to as “CCA occlusion” [CCAO]) in rats was employed in this study. Seven days after the CCAO procedure, the authors performed encephalo-myo-synangiosis (EMS) and injected plasmid(s) into each rat's temporal muscle. Rats were divided into 4 groups based on which plasmid was received (i.e., LacZ group, VEGF group, apelin group, and VEGF+apelin group). Protein levels in the cortex and attached muscle were assessed with enzyme-linked immunosorbent assay (ELISA) on Day 7 after EMS, while immunofluorescent analysis of cortical vessels was performed on Day 14 after EMS.

RESULTS

The total number of blood vessels in the cortex on Day 14 after EMS was significantly larger in the VEGF group and the VEGF+apelin group than in the LacZ group (p < 0.05, respectively). Larger vessels appeared in the VEGF+apelin group than in the other groups (p < 0.05, respectively). Apelin protein on Day 7 after EMS was not detected in the cortex for any of the groups. In the attached muscle, apelin protein was detected only in the apelin group and the VEGF+apelin group. Immunofluorescent analysis revealed that apelin and its receptor, APJ, were expressed on endothelial cells (ECs) 7 days after the CCAO.

CONCLUSIONS

Combined gene therapy (VEGF plus apelin) during EMS in a chronic cerebral hypoperfusion model can enhance angiogenesis in rats. This treatment has the potential to be a feasible option in a clinical setting for patients with moyamoya disease.

ABBREVIATIONS

Ang-1 = angiopoietin-1; CBF = cerebral blood flow; CCA = common carotid artery; CCAO = CCA occlusion; EC = endothelial cells; ELISA = enzyme-linked immunosorbent assay; EMS = encephalo-myo-synangiosis; MMD = moyamoya disease; PBS = phosphate-buffered saline; PFA = paraformaldehyde; RECA-1 = mouse monoclonal anti-EC antibody; VEGF = vascular endothelial growth factor.
  • Collapse
  • Expand
  • 1

    Anan M, Abe T, Matsuda T, Ishii K, Kamida T, Fujiki M, et al.: Induced angiogenesis under cerebral ischemia by cyclooxygenase 2 and hypoxia-inducible factor naked DNA in a rat indirect-bypass model. Neurosci Lett 409:118123, 2006

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 2

    Anan M, Abe T, Shimotaka K, Kamida T, Kubo T, Fujiki M, et al.: Induction of collateral circulation by hypoxia-inducible factor 1alpha decreased cerebral infarction in the rat. Neurol Res 31:917922, 2009

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 3

    Arsic N, Zentilin L, Zacchigna S, Santoro D, Stanta G, Salvi A, et al.: Induction of functional neovascularization by combined VEGF and angiopoietin-1 gene transfer using AAV vectors. Mol Ther 7:450459, 2003

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4

    Baumgartner I, Rauh G, Pieczek A, Wuensch D, Magner M, Kearney M, et al.: Lower-extremity edema associated with gene transfer of naked DNA encoding vascular endothelial growth factor. Ann Intern Med 132:880884, 2000

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 5

    Chae JK, Kim I, Lim ST, Chung MJ, Kim WH, Kim HG, et al.: Coadministration of angiopoietin-1 and vascular endothelial growth factor enhances collateral vascularization. Arterioscler Thromb Vasc Biol 20:25732578, 2000

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 6

    Dai T, Ramirez-Correa G, Gao WD: Apelin increases contractility in failing cardiac muscle. Eur J Pharmacol 553:222228, 2006

  • 7

    Eyries M, Siegfried G, Ciumas M, Montagne K, Agrapart M, Lebrin F, et al.: Hypoxia-induced apelin expression regulates endothelial cell proliferation and regenerative angiogenesis. Circ Res 103:432440, 2008

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 8

    Farkas E, Luiten PG, Bari F: Permanent, bilateral common carotid artery occlusion in the rat: a model for chronic cerebral hypoperfusion-related neurodegenerative diseases. Brain Res Brain Res Rev 54:162180, 2007

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 9

    Festa JR, Schwarz LR, Pliskin N, Cullum CM, Lacritz L, Charbel FT, et al.: Neurocognitive dysfunction in adult moyamoya disease. J Neurol 257:806815, 2010

  • 10

    Gavard J, Gutkind JS: VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin. Nat Cell Biol 8:12231234, 2006

  • 11

    Harrigan MR, Ennis SR, Masada T, Keep RF: Intraventricular infusion of vascular endothelial growth factor promotes cerebral angiogenesis with minimal brain edema. Neurosurgery 50:589598, 2002

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 12

    Hecht N, Marushima A, Nieminen M, Kremenetskaia I, von Degenfeld G, Woitzik J, et al.: Myoblast-mediated gene therapy improves functional collateralization in chronic cerebral hypoperfusion. Stroke 46:203211, 2015

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 13

    Karzmark P, Zeifert PD, Tan S, Dorfman LJ, Bell-Stephens TE, Steinberg GK: Effect of moyamoya disease on neuropsychological functioning in adults. Neurosurgery 62:10481052, 2008

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 14

    Kasai A, Shintani N, Oda M, Kakuda M, Hashimoto H, Matsuda T, et al.: Apelin is a novel angiogenic factor in retinal endothelial cells. Biochem Biophys Res Commun 325:395400, 2004

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 15

    Katsumata A, Sugiu K, Tokunaga K, Kusaka N, Watanabe K, Nishida A, et al.: Optimal dose of plasmid vascular endothelial growth factor for enhancement of angiogenesis in the rat brain ischemia model. Neurol Med Chir (Tokyo) 50:449455, 2010

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 16

    Kevil CG, Payne DK, Mire E, Alexander JS: Vascular permeability factor/vascular endothelial cell growth factor-mediated permeability occurs through disorganization of endothelial junctional proteins. J Biol Chem 273:1509915103, 1998

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 17

    Kidoya H, Naito H, Takakura N: Apelin induces enlarged and nonleaky blood vessels for functional recovery from ischemia. Blood 115:31663174, 2010

  • 18

    Kidoya H, Ueno M, Yamada Y, Mochizuki N, Nakata M, Yano T, et al.: Spatial and temporal role of the apelin/APJ system in the caliber size regulation of blood vessels during angiogenesis. EMBO J 27:522534, 2008

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 19

    Kim HS, Lee HJ, Yeu IS, Yi JS, Yang JH, Lee IW: The neovascularization effect of bone marrow stromal cells in temporal muscle after encephalomyosynangiosis in chronic cerebral ischemic rats. J Korean Neurosurg Soc 44:249255, 2008

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 20

    Kim SK, Cho BK, Phi JH, Lee JY, Chae JH, Kim KJ, et al.: Pediatric moyamoya disease: An analysis of 410 consecutive cases. Ann Neurol 68:92101, 2010

  • 21

    Kuroda S, Houkin K: Moyamoya disease: current concepts and future perspectives. Lancet Neurol 7:10561066, 2008

  • 22

    Kusaka N, Sugiu K, Tokunaga K, Katsumata A, Nishida A, Namba K, et al.: Enhanced brain angiogenesis in chronic cerebral hypoperfusion after administration of plasmid human vascular endothelial growth factor in combination with indirect vasoreconstructive surgery. J Neurosurg 103:882890, 2005

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 23

    Lee DK, Cheng R, Nguyen T, Fan T, Kariyawasam AP, Liu Y, et al.: Characterization of apelin, the ligand for the APJ receptor. J Neurochem 74:3441, 2000

  • 24

    Lee RJ, Springer ML, Blanco-Bose WE, Shaw R, Ursell PC, Blau HM: VEGF gene delivery to myocardium: deleterious effects of unregulated expression. Circulation 102:898901, 2000

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 25

    Lee SB, Kim DS, Huh PW, Yoo DS, Lee TG, Cho KS: Long-term follow-up results in 142 adult patients with moyamoya disease according to management modality. Acta Neurochir (Wien) 154:11791187, 2012

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 26

    Masri B, Morin N, Cornu M, Knibiehler B, Audigier Y: Apelin (65-77) activates p70 S6 kinase and is mitogenic for umbilical endothelial cells. FASEB J 18:19091911, 2004

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 27

    Mizoi K, Kayama T, Yoshimoto T, Nagamine Y: Indirect revascularization for moyamoya disease: is there a beneficial effect for adult patients?. Surg Neurol 45:541549, 1996

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 28

    Nakamura M, Imai H, Konno K, Kubota C, Seki K, Puentes S, et al.: Experimental investigation of encephalomyosynangiosis using gyrencephalic brain of the miniature pig: histopathological evaluation of dynamic reconstruction of vessels for functional anastomosis. Laboratory investigation. J Neurosurg Pediatr 3:488495, 2009

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 29

    O'Carroll AM, Selby TL, Palkovits M, Lolait SJ: Distribution of mRNA encoding B78/apj, the rat homologue of the human APJ receptor, and its endogenous ligand apelin in brain and peripheral tissues. Biochim Biophys Acta 1492:7280, 2000

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 30

    O'Donnell LA, Agrawal A, Sabnekar P, Dichter MA, Lynch DR, Kolson DL: Apelin, an endogenous neuronal peptide, protects hippocampal neurons against excitotoxic injury. J Neurochem 102:19051917, 2007

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 31

    Ohmori Y, Morioka M, Kaku Y, Kawano T, Kuratsu J: Granulocyte colony-stimulating factor enhances the angiogenetic effect of indirect bypass surgery for chronic cerebral hypoperfusion in a rat model. Neurosurgery 68:13721379, 2011

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 32

    Pandey P, Steinberg GK: Outcome of repeat revascularization surgery for moyamoya disease after an unsuccessful indirect revascularization. Clinical article. J Neurosurg 115:328336, 2011

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 33

    Park YS, Jeon YJ, Kim HS, Chae KY, Oh SH, Han IB, et al.: The role of VEGF and KDR polymorphisms in moyamoya disease and collateral revascularization. PLoS One 7:e47158, 2012

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 34

    Samuel SM, Akita Y, Paul D, Thirunavukkarasu M, Zhan L, Sudhakaran PR, et al.: Coadministration of adenoviral vascular endothelial growth factor and angiopoietin-1 enhances vascularization and reduces ventricular remodeling in the infarcted myocardium of type 1 diabetic rats. Diabetes 59:5160, 2010

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 35

    Schwarz ER, Speakman MT, Patterson M, Hale SS, Isner JM, Kedes LH, et al.: Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial infarction model in the rat—angiogenesis and angioma formation. J Am Coll Cardiol 35:13231330, 2000

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 36

    Takakura N, Kidoya H: Maturation of blood vessels by haematopoietic stem cells and progenitor cells: involvement of apelin/APJ and angiopoietin/Tie2 interactions in vessel caliber size regulation. Thromb Haemost 101:9991005, 2009

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 37

    Tanaka K, Ogawa N, Asanuma M, Kondo Y, Nomura M: Relationship between cholinergic dysfunction and discrimination learning disabilities in Wistar rats following chronic cerebral hypoperfusion. Brain Res 729:5565, 1996

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 38

    Tashiro H, Aoki M, Isobe M, Hashiya N, Makino H, Kaneda Y, et al.: Development of novel method of non-viral efficient gene transfer into neonatal cardiac myocytes. J Mol Cell Cardiol 39:503509, 2005

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 39

    Touho H, Karasawa J, Ohnishi H, Yamada K, Shibamoto K: Surgical reconstruction of failed indirect anastomosis in childhood Moyamoya disease. Neurosurgery 32:935940, 1993

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 40

    Toyama K, Honmou O, Harada K, Suzuki J, Houkin K, Hamada H, et al.: Therapeutic benefits of angiogenetic gene-modified human mesenchymal stem cells after cerebral ischemia. Exp Neurol 216:4755, 2009

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 41

    Yamauchi A, Ito Y, Morikawa M, Kobune M, Huang J, Sasaki K, et al.: Pre-administration of angiopoietin-1 followed by VEGF induces functional and mature vascular formation in a rabbit ischemic model. J Gene Med 5:9941004, 2003

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 274 70 28
Full Text Views 1075 110 3
PDF Downloads 1010 108 5
EPUB Downloads 0 0 0